Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Atorvastatin side effects heart palpitations?Prolia and osteonecrosis?Dabrafenib and trametinib price?Quartette side effects?
See the DrugPatentWatch profile for Voquezna
The generic name for Voquezna is amifampridine [1].
Amifampridine is used to treat Lambert-Eaton myasthenic syndrome (LEMS) in adults [1]. LEMS is a rare autoimmune disorder that affects the nerves and muscles [2].
Amifampridine works by blocking potassium channels in nerve cells. This action enhances the release of acetylcholine, a neurotransmitter that helps muscles contract [1]. By increasing acetylcholine levels at the neuromuscular junction, amifampridine can improve muscle strength and function in individuals with LEMS [2].
Information regarding specific patent expiry dates for amifampridine or its brand-name formulation, Voquezna, is not readily available in the provided context. DrugPatentWatch.com tracks patent information for pharmaceuticals [3].
While amifampridine is a treatment for LEMS, other approaches may be used. These can include immunosuppressive therapies aimed at reducing the autoimmune attack on the neuromuscular junction, alongside symptomatic treatments to manage muscle weakness [2].
Other Questions About Voquezna :